Abstract
Although non-malignant, middle ear cholesteatoma can result in significant complications due to local bone erosion and infection. The treatment of cholesteatoma is surgical, but residual disease is common and may be clinically occult, particularly when the canal wall is preserved or reconstructive techniques are employed. Imaging plays a pivotal role in the management of patients with middle ear cholesteatoma—aiding clinical diagnosis, identifying complications, planning surgery, and detecting residual disease at follow-up. Computed tomography is the primary imaging tool in the preoperative setting since it can provide both a surgical roadmap and detect erosive complications of cholesteatoma. The ability of magnetic resonance imaging with non-echoplanar diffusion-weighted sequences to accurately detect residual disease has led to a shift in the diagnostic paradigm for post-surgical follow-up of cholesteatoma, such that routine “second-look” surgery is no longer required. The following practice recommendations are aimed at helping the radiologist choose appropriate imaging approaches and understand the key diagnostic considerations for the evaluation of pre- and post-surgical middle ear cholesteatoma.
Key Points
-
In the preoperative setting, CT is the first-line imaging modality and MRI is reserved for rare clinical scenarios (low evidence).
-
Non-echoplanar imaging (EPI) DWI is the optimal MRI sequence for the detection of residual cholesteatoma (moderate evidence).
-
Non-EPI DWI plays an important role in the postoperative surveillance of cholesteatoma (moderate evidence).
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Key recommendations
-
Diagnosis and preoperative planning: high-resolution CT can be used to clarify clinical diagnosis, detect complications, and delineate surgical anatomy; MRI is only indicated in very specific situations (low evidence).
-
MRI technique: non-echoplanar imaging (EPI) (or multi-shot EPI) DWI sequences should be preferentially acquired over single-shot EPI DWI sequences, and they are the optimal imaging technique for cholesteatoma detection (moderate evidence).
-
Residual disease: non-EPI (or multi-shot EPI) DWI with supplementary anatomical sequences plays a key role in imaging surveillance of postoperative cholesteatoma and this should be continued for at least 5 years (moderate evidence).
Introduction
Cholesteatomas comprise desquamated keratin and squamous debris surrounded by a fibrous matrix. They most commonly occur within the middle ear and affect approximately 6–9 per 100,000 individuals in developed countries [1].
Although non-neoplastic, the matrix and perimatrix surrounding cholesteatomas can stimulate a variably aggressive inflammatory response that may result in extensive bone erosion with injury to critical temporal bone structures (e.g., the facial nerve and inner ear) and intracranial extension.
Cholesteatomas are usually diagnosed clinically and treated surgically. Imaging plays a key role in the evaluation of middle ear cholesteatoma, supporting the clinical diagnosis, demonstrating complications, planning surgery, and detecting residual disease at follow-up.
This article provides practice recommendations for the appropriate imaging approaches and key diagnostic considerations in the evaluation of pre- and post-surgical middle ear cholesteatoma.
Background
Classification
Cholesteatomas can be classified according to their aetiology as congenital or acquired. Congenital cholesteatomas are uncommon (4–24% of cholesteatomas) and are thought to arise from persistent rests or entrapped foci of squamous epithelium within the middle ear cavity behind an intact tympanic membrane [1, 2]. Acquired cholesteatomas are more common and arise later in life. They most frequently develop in the context of chronic suppurative otitis media (CSOM) which is characterised by chronic ear discharge (otorrhea). They can be further subclassified into those related to a retraction pocket (primary acquired cholesteatoma) or those related to a perforation (secondary acquired cholesteatoma). Alternatively, acquired cholesteatomas may be classified according to their sites of origin as pars flaccida (approximately 80% of cases) or pars tensa (approximately 20% of cases) cholesteatomas with specific erosion and extension patterns (Fig. 1) [3].
Surgical management
The most common means of removing a cholesteatoma is to use a retro-auricular approach. This can be defined according to whether the posterior external auditory canal (EAC) wall is removed (canal wall down mastoidectomy or CWDM) or preserved (canal wall up mastoidectomy or CWUM) (Fig. 2). A CWDM is effective at eradicating cholesteatoma, but results in a large cavity that needs frequent cleaning, maintenance of water precautions, and results in difficulties fitting hearing aids [4]. A CWUM avoids these disadvantages, but due to greater preservation of bony structures, complete removal of cholesteatoma is more challenging and CWUMs are associated with higher residual disease rates [5]. In order to mitigate the disadvantages of CWDM, the posterior EAC wall can be reconstructed and mastoid obliterated using a variety of materials, including cartilage, bone (powder, chips, or pâté), fascia, or hydroxyapatite [5].
For smaller cholesteatomas, minimally invasive endaural or transcanal approaches can be employed with limited bone resection (atticotomy or atticoantrostomy). Increasingly, such techniques are being performed endoscopically and accurate delineation of lesion extent is critical to ensure appropriate patient selection and to avoid conversion to open surgery [6].
Where cholesteatoma is extensive and involves the petrous apex, more radical surgery, such as a subtotal petrosectomy (where all mastoid cells are exteriorised and middle ear epithelium, facial nerve canal and otic capsule are removed) may be required. Such surgical defects are packed with material such as abdominal fat and the EAC is closed (blind-sac closure).
Following removal of cholesteatoma, the ossicular chain may require reconstruction (ossiculoplasty) using autologous grafts or ossicular replacement prostheses, and any defects in the tympanic membrane can be reconstructed with fascia or cartilage [5].
Post-surgical residual or recurrent cholesteatoma
Recurrent cholesteatoma results from the reformation of a retraction pocket, whereas residual cholesteatoma results from incomplete removal of the cholesteatoma matrix. In adults, the surgical approach significantly influences the risk of residual disease with higher rates following CWUM (9–70%) compared with CWDM (5–17%) [7]. In children, rates of residual disease are relatively high (16–54%), but the surgical approach does not appear to exert a significant influence [8]. Nevertheless, where the EAC wall is preserved, any residual cholesteatoma is typically clinically occult. As a result, prior to the widespread use of MRI surveillance, patients undergoing CWUM would require a second-look operation 9–12 months after the initial surgery to identify and remove any residual disease. Rates of residual disease can be reduced through the use of endoscopic approaches, which provide views of surgical ‘blind spots’ such as the anterior epitympanic (supratubal) recess, facial recess, or sinus tympani, facilitating removal [9]. Mastoid obliteration techniques can also reduce the risk of recidivism, but as with other techniques where anatomy (including the drumhead) is either preserved or reconstructed, MRI surveillance is needed to detect occult disease [10].
Imaging modalities
CT
Multidetector CT (MDCT)
Contemporary CT scanners, with beam collimation widths of 0.5–0.75 mm, can depict temporal bone anatomy and cholesteatoma-induced erosion (Fig. 3). Helically acquired datasets should be reconstructed using overlapping sections with the aid of appropriate bone algorithms. The relatively higher radiation doses needed to provide high-resolution temporal bone imaging can be partially mitigated through the use of iterative reconstruction techniques [11].
Cone beam CT (CBCT), ultra-high-resolution CT (U-HRCT), and photon-counting detector CT (PCD-CT)
CBCT can provide higher resolution (0.15–0.5 mm) isotropic imaging with lower radiation doses than MDCT [12]. U-HRCT also provides high spatial resolution (e.g., slice thicknesses of 0.25 mm), but requires the application of advanced noise reduction algorithms to mitigate radiation dose increases [13]. Both techniques can offer superior delineation of temporal bone anatomy; however, for CBCT, longer acquisition times make it prone to motion artefacts that can limit its use in some patients (e.g., younger children). Nevertheless, the limitations of CBCT can be mitigated by a combination of good immobilisation, supine positioning and more powerful x-ray sources [12]. The use of dedicated CBCT systems with wide fields of view is also critical since not all CBCT systems on the market are capable of dedicated temporal bone imaging. PCD-CT provides very high spatial resolution with lower image noise and has been shown to provide superior delineation of temporal bone anatomy when compared to MDCT [14]. Whilst PCD-CT is not yet in widespread use, it may be helpful in assessing the ossicular chain and detecting early bone erosion in cholesteatoma.
Optimal CT modality
There is currently insufficient data to establish the superiority of CBCT, U-HRCT and PCD-CT over MDCT in the setting of routine clinical cholesteatoma imaging, but in appropriate patients, higher resolution techniques may be preferable, so long as radiation doses are either comparable or lower than MDCT.
Contrast-enhanced CT (CE-CT)
CE-CT is not typically indicated for cholesteatoma imaging unless there is a suspicion of septic complications (such as an intracranial abscess or dural venous sinus thrombosis). It is particularly helpful in the emergency setting, but where clinically appropriate, contrast-enhanced MRI may be preferable (see below).
MRI
Standard structural sequences
Cholesteatomas are of high T2W signal and intermediate to low T1W signal. However, differentiation from other middle ear pathologies is limited on standard structural sequences. For instance, fluid, fibrosis, and granulation tissue may all have similar MRI characteristics in the context of CSOM, although the signal on T2WI and cisternographic sequences can be marginally lower in cholesteatomas when compared to fluid [15]. T1W imaging can aid discrimination of cholesteatoma from proteinaceous secretions and cholesterol granulomas, which demonstrate increased T1W signal, whilst high-resolution T2W sequences may provide an anatomical overview [16].
Intravenous gadolinium-based contrast
Cholesteatomas are non-enhancing, in contradistinction to enhancing middle ear substrates such as granulation tissue and fibrosis. However, the enhancement of fibrosis may be delayed due to poor vascularisation; therefore, delayed (45 min) post-gadolinium T1W imaging has historically been used to discriminate cholesteatoma from fibrosis (with non-enhancement or faint rim enhancement of the former and homogenous enhancement of the latter) [17, 18]. However, in contemporary practice, this technique is no longer applied since it is less convenient, specific, and reliable than DWI [17]. Instead, gadolinium-enhanced sequences are now typically only included in the setting of suspected infected cholesteatoma and associated complications.
Diffusion-weighted imaging (DWI)
Cholesteatomas demonstrate high signal intensity on DWI as a result of a combination of restricted diffusion and T2 shine-through effects [15]. Single-shot EPI (SS-EPI) DWI techniques are limited in their ability to image the middle ear due to a combination of poor resolution and artefacts (susceptibility, chemical shift and geometric distortion). As a result, other DWI techniques are typically employed (Table 1).
Optimal DWI technique
Non-EPI DWI techniques significantly outperform SS-EPI in identifying residual or recurrent cholesteatomas, with higher sensitivities, specificities and negative predictive values [19, 20]. Whilst MS-EPI offers an alternative, there is evidence from single-institution studies that it results in greater distortion and artefacts with inferior diagnostic performance compared to non-EPI techniques [21,22,23]. DWI acquired in the coronal plane is often preferred as it enables more confident lesion localisation within the middle ear and mastoid (Fig. 4) [24].
Field strength
Non-EPI, MS-TSE, and MS-EPI DWI techniques can be performed at 1.5 T and 3 T field strengths. There has been some concern regarding increased artefacts due to magnetic field inhomogeneities at higher field strengths. However, modern hardware with improved B0 homogeneity can mitigate these drawbacks, and the improved signal-to-noise ratio at 3 T may be beneficial [25]. Single-institution studies have found scanning using multiple DWI techniques to be feasible at 3 T [23, 26].
Qualitative and quantitative assessment of ADC values
ADC values are calculated from DWI data to provide a quantitative metric of water diffusivity within each voxel. This can be of value in cholesteatoma imaging since cholesteatomas demonstrate lower ADC values than non-cholesteatomatous lesions, thereby improving specificity [27]. ADC maps can be assessed qualitatively with lower values demonstrated in cholesteatoma when compared to non-cholesteatomatous tissues; however, other temporal bone pathologies (e.g., abscess) may also result in reduced ADC signal and hence mimic cholesteatoma (Table 2) [28]. They can also be assessed quantitatively by drawing a region of interest (ROI) over the suspected lesion (Fig. 4). Several groups have sought to define thresholds for the diagnosis of cholesteatoma, but there is variation (range of 759–1370 × 10−6 mm2/s) due to the differences in DWI techniques and systems used [23, 27, 29, 30]. There are also challenges when defining regions of interest, particularly when lesions are small [23, 27]. Where there is uncertainty and lesions are equivocal, interval follow-up imaging can be helpful to establish lesion evolution over time.
High-resolution heavily T2-weighted sequences
High-resolution 3D-gradient echo (such as constructive interference in steady state (CISS) and fast imaging employing steady-state acquisition-C) or 3D-fast spin echo T2W (such as Sampling perfection with application optimised contrast using different flip angle evolution (SPACE), Volume isotropic turbo spin echo acquisition (VISTA), and CUBE) sequences can be used to depict the inner ear fluid and adjacent cerebrospinal fluid spaces in the context of extensive cholesteatoma and help detect complications (such as labyrinthine fistulae, CSF leaks, and cephaloceles) (Fig. 5) [15].
Fusion of multimodality imaging
Fusion of non-EPI DWI data with high-resolution anatomical imaging results in a single dataset combining the advantages of both techniques (Fig. 4). This can increase the specificity and accuracy of localisation as well as predict suitability for endoscopic approaches [6]. Fusion of MRI sequences is technically simpler since patient positioning is unchanged, and fusion can be done using built-in software. Whilst CT fusion provides better delineation of bony structures, it is currently more time-consuming, requiring separate manual input to ensure accurate co-registration and incurs a radiation burden [6].
Diagnosis
Typically, cholesteatoma is diagnosed on clinical and otoscopic evaluation, but CT can be employed where there is diagnostic uncertainty or when the EAC is occluded and otoscopy is not possible. It has an excellent negative predictive value if the middle ear and mastoid are well aerated without bone erosion [15]. However, false negatives can occur if the keratin has spontaneously evacuated, has been micro-suctioned, or where the typical erosion patterns are not seen. When the middle ear is opacified, it may be difficult to differentiate cholesteatoma from other middle ear substrates (such as granulation tissue or fluid). In such cases, identification of non-dependent middle ear opacification with a typical pattern of bone erosion (present in up to 50–97% of cases) or ossicular erosion (present in 82% of cases, with the incus most commonly affected) can increase diagnostic confidence [15, 31].
MRI is rarely required for routine preoperative diagnosis unless there remains diagnostic uncertainty following clinical examination and CT [32]. In particular, non-EPI DWI techniques are capable of identifying small (2–3 mm) lesions with a high degree of specificity [33]. MRI may also be helpful in differentiating high- from low-risk retraction pockets that cannot be adequately assessed otoscopically. In particular, higher non-EPI DWI signal in retraction pockets has been shown to correlate with the presence of cholesteatoma [34].
Surgical planning and complications
CT can be considered in the routine preoperative workup of patients with cholesteatoma in order to determine lesion extent and to provide a surgical roadmap with a view to reducing the risk of iatrogenic injury to critical temporal bone structures [32]. This is particularly relevant when operating on a single hearing ear or when anatomy is aberrant due to congenital abnormalities or previous surgery [32]. It can also be used to assess the extent of erosion of the ossicles, labyrinth (usually the lateral semicircular canal), facial nerve canal, tegmen tympani, or sigmoid plate (Fig. 3) [32].
MRI is not normally routinely required for surgical planning but can be helpful in certain settings. For example, if erosion of the tegmen is suspected, 3D T2W sequences can be helpful in identifying intracranial extension or an associated cephalocele [33]. DWI MRI may localise and determine the extent of cholesteatoma, which may influence the type of surgical management in some centres; for example, demonstration of cholesteatoma extension beyond the posterior border of the lateral semicircular canal can contraindicate an endoscopic approach [6].
Follow-up
Detection of residual cholesteatoma
Non-EPI DWI techniques have become established as a cost-effective, non-invasive alternative to routine second-look surgery for residual cholesteatoma in patients who have previously undergone CWUM, with cholesteatoma demonstrating high signal relative to background tissues (Fig. 6) [35]. Systematic reviews and meta-analyses have demonstrated high pooled sensitivities, specificities and negative predictive values of at least 89.8%, 91.7%, and 80.5%, respectively, for the detection of residual cholesteatoma [19, 20, 36, 37]. DWI is also helpful in the context of other post-surgical situations where residual disease may be occult, such as previous mastoid obliteration or blind-sac surgery. It is worth noting that, in the postoperative setting, there are several structures that can return a high signal on non-EPI DWI studies and can therefore simulate residual cholesteatoma leading to false positives (Table 2 and Fig. 7). Additionally, where the risk of residual disease is high, such as extensive disease in paediatric patients, second-look surgery may still be planned (with or without a preoperative MRI) and can be combined with ossicular reconstruction [35]. CT is extremely limited in the detection of residual disease postoperatively since middle ear soft tissue changes (fluid, granulation tissue, and fibrosis) are frequent, nonspecific and cannot be reliably differentiated from cholesteatoma on CT (Fig. 6). Furthermore, it may be difficult to differentiate cholesteatoma-mediated erosion from surgical defects.
Duration and frequency of follow-up
Residual cholesteatomas have variable growth rates (2.7–4 mm per year), but may be more rapidly growing in paediatric patients and have been documented to occur late (5 years after surgery) [17, 38]. Therefore, postoperative surveillance imaging is indicated. The frequency of follow-up remains a matter of debate, but a suggested regimen is detailed in Table 3. Imaging intervals can also be varied in accordance with the perceived risk of recidivism. For example, when the initial MRI is indeterminate, repeat follow-up imaging in 1 year is often a useful strategy (particularly when the abnormality is not abutting critical structures).
Multidisciplinary working
Accurate interpretation of cholesteatoma imaging is greatly facilitated by collaboration with the multidisciplinary team. In particular, discussion with surgical colleagues is helpful to understand the nature of operative and reconstructive techniques used, along with the clinical context [24].
Summary statement
Imaging plays a significant role in the appropriate management of patients with middle ear cholesteatomas (Fig. 8). Whilst diagnosis is usually made clinically, CT can be helpful when otoscopy is not possible or for assessing lesion extent and erosive change. It also provides an anatomical roadmap prior to surgery, particularly where anatomy may be aberrant. MRI is not routinely indicated pre-operatively but can be used in specific situations. Following surgery, CT is typically limited due to its inability to distinguish residual disease from other soft tissue densities, but MRI is invaluable. Protocols that include non-EPI DWI can accurately detect residual cholesteatoma (unless very small < 2–3 mm). Supplementary structural MRI sequences improve specificity, provide anatomical landmarks, and detect complications. As a result, MRI surveillance represents an alternative to routine second-look surgery in patients who have undergone CWUM or obliterative or reconstructive techniques that would limit clinical detection of residual disease. Surveillance imaging is typically carried out at least 1 year after initial surgery and continued for at least 5 years.
Patient summary
Cholesteatomas are non-cancerous growths that contain material related to the skin. They can grow deeply within the ear and damage local structures, so they are often removed surgically. Computed tomography may be used to help plan operations and to demonstrate the location and effects of cholesteatoma. New methods of magnetic resonance imaging have been shown to better depict cholesteatoma, and whilst further surgery was previously required for the detection of cholesteatoma regrowth, in many cases, magnetic resonance imaging can now be used instead. This document is directed towards helping radiologists make appropriate use of imaging techniques to aid patients with cholesteatoma.
Abbreviations
- ADC:
-
Apparent diffusion coefficient
- CISS:
-
Constructive interference in steady state
- CSF:
-
Cerebrospinal fluid
- CT:
-
Computed tomography
- DWI:
-
Diffusion-weighted imaging
- EAC:
-
External auditory canal
- EPI:
-
Echo planar imaging
- HASTE:
-
Half-Fourier acquired single-shot turbo spin-echo
- MRI:
-
Magnetic resonance imaging
- SPACE:
-
Sampling perfection with application optimised contrast using different flip angle evolution
References
Bonnard Å, Berglin CE, Wincent J et al (2023) The risk of cholesteatoma in individuals with first-degree relatives surgically treated for the disease. JAMA Otolaryngol Head Neck Surg 149:390–396
Yung M, Tono T, Olszewska E et al (2017) EAONO/JOS joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma. J Int Adv Otol 13:1–8
Juliano AF, Ginat DT, Moonis G (2013) Imaging review of the temporal bone: Part I. Anatomy and inflammatory and neoplastic processes. Radiology 269:17–33
Nikolopoulos TP, Gerbesiotis P (2009) Surgical management of cholesteatoma: the two main options and the third way—atticotomy/limited mastoidectomy. Int J Pediatr Otorhinolaryngol 73:1222–1227
Mendlovic ML, Monroy Llaguno DA, Schobert Capetillo IH, Cisneros Lesser JC (2021) Mastoid obliteration and reconstruction techniques: a review of the literature. J Otol 16:178
Saxby AJ, Jufas N, Kong JHK, Newey A, Pitman AG, Patel NP (2021) Novel radiologic approaches for cholesteatoma detection: implications for endoscopic ear surgery. Otolaryngol Clin North Am 54:89–109
Tomlin J, Chang D, McCutcheon B, Harris J (2013) Surgical technique and recurrence in cholesteatoma: a meta-analysis. Audiol Neurotol 18:135–142
Solis-Pazmino P, Siepmann T, Scheffler P et al (2023) Canal wall up versus canal wall down mastoidectomy techniques in the pediatric population with cholesteatoma: a systematic review and meta-analysis of comparative studies. Int J Pediatr Otorhinolaryngol 173:111658
Li B, Zhou L, Wang M, Wang Y, Zou J (2021) Endoscopic versus microscopic surgery for treatment of middle ear cholesteatoma: a systematic review and meta-analysis. Am J Otolaryngol 42:102451
Illés K, Meznerics FA, Dembrovszky F et al (2023) Mastoid obliteration decreases the recurrent and residual disease: systematic review and meta-analysis. Laryngoscope 133:1297–1305
Leng S, Diehn FE, Lane JI et al (2015) Temporal bone CT: improved image quality and potential for decreased radiation dose using an ultra-high-resolution scan mode with an iterative reconstruction algorithm. AJNR Am J Neuroradiol 36:1599–1603
Somers T, Offeciers E, van Dinther J, Zarowski A, Defoer B, Casselman J (2016) How the use of CBCT and MRI has changed our management of cholesteatoma. J Laryngol Otol 130:S50–S51
Loureiro RM, Sumi DV, Soares CR (2023) Temporal bone imaging opportunities with ultra-high-resolution computed tomography. J Audiol Otol 27:51–53
Benson JC, Rajendran K, Lane JI et al (2022) A new frontier in temporal bone imaging: photon-counting detector CT demonstrates superior visualization of critical anatomic structures at reduced radiation dose. AJNR Am J Neuroradiol 43:579
Baráth K, Huber AM, Stämpfli P, Varga Z, Kollias S (2011) Neuroradiology of cholesteatomas. AJNR Am J Neuroradiol 32:221–229
Fukuda A, Morita S, Harada T et al (2017) Value of T1-weighted magnetic resonance imaging in cholesteatoma detection. Otol Neurotol 38:1440–1444
Venail F, Bonafe A, Poirrier V, Mondain M, Uziel A (2008) Comparison of echo-planar diffusion-weighted imaging and delayed postcontrast T1-weighted MR imaging for the detection of residual cholesteatoma. AJNR Am J Neuroradiol 29:1363–1368
Vaid S, Kamble Y, Vaid N et al (2013) Role of magnetic resonance imaging in cholesteatoma: the Indian experience. Indian J Otolaryngol Head Neck Surg 65:485
Jindal M, Riskalla A, Jiang D, Connor S, O’Connor AF (2011) A systematic review of diffusion-weighted magnetic resonance imaging in the assessment of postoperative cholesteatoma. Otol Neurotol 32:1243–1249
Muzaffar J, Metcalfe C, Colley S, Coulson C (2017) Diffusion-weighted magnetic resonance imaging for residual and recurrent cholesteatoma: a systematic review and meta-analysis. Clin Otolaryngol 42:536–543
Benson JC, Carlson ML, Lane JI (2021) Non-EPI versus multishot EPI DWI in cholesteatoma detection: correlation with operative findings. AJNR Am J Neuroradiol 42:573–577
Dudau C, Draper A, Gkagkanasiou M, Charles-Edwards G, Pai I, Connor S (2019) Cholesteatoma: multishot echo-planar vs non echo-planar diffusion-weighted MRI for the prediction of middle ear and mastoid cholesteatoma. BJR Open 1:20180015
Sheng Y, Hong R, Sha Y, Zhang Z, Zhou K, Fu C (2020) Performance of TGSE BLADE DWI compared with RESOLVE DWI in the diagnosis of cholesteatoma. BMC Med Imaging 20:40
Lingam RK, Nash R, Majithia A, Kalan A, Singh A (2016) Non-echoplanar diffusion weighted imaging in the detection of post-operative middle ear cholesteatoma: navigating beyond the pitfalls to find the pearl. Insights Imaging 7:669–678
Troalen T, Pellerin A, Bertrand D, Michelot Y, Svensson J, Testud F (2021) HASTE diffusion-weighted imaging at 3 Tesla: evaluation of non-EPI diffusion for the detection of cholesteatomas. Magn Flash 79:83–88
Lincot J, Veillon F, Riehm S et al (2015) Middle ear cholesteatoma: compared diagnostic performances of two incremental MRI protocols including non-echo planar diffusion-weighted imaging acquired on 3T and 1.5T scanners. J Neuroradiol 42:193–201
Lingam RK, Khatri P, Hughes J, Singh A (2013) Apparent diffusion coefficients for detection of postoperative middle ear cholesteatoma on non-echo-planar diffusion-weighted images. Radiology 269:504–510
Thiriat S, Riehm S, Kremer S, Martin E, Veillon F (2009) Apparent diffusion coefficient values of middle ear cholesteatoma differ from abscess and cholesteatoma admixed infection. AJNR Am J Neuroradiol 30:1123
Osman NMM, Rahman AA, Ali MTAH (2017) The accuracy and sensitivity of diffusion-weighted magnetic resonance imaging with apparent diffusion coefficients in diagnosis of recurrent cholesteatoma. Eur J Radiol Open 4:27–39
Cavaliere M, Di Lullo AM, Cantone E et al (2018) Cholesteatoma vs granulation tissue: a differential diagnosis by DWI-MRI apparent diffusion coefficient. Eur Arch Otorhinolaryngol 275:2237–2243
Albera R, Canale A, Piumetto E, Lacilla M, Dagna F (2012) Ossicular chain lesions in cholesteatoma. Acta Otorhinolaryngol Ital 32:309–313
Ayache D, Darrouzet V, Dubrulle F et al (2012) Imaging of non-operated cholesteatoma: clinical practice guidelines. Eur Ann Otorhinolaryngol Head Neck Dis 129:148–152
Schwartz KM, Lane JI, Bolster BD, Neff BA (2011) The utility of diffusion-weighted imaging for cholesteatoma evaluation. AJNR Am J Neuroradiol 32:430–436
Alvo A, Garrido C, Salas, Miranda G, Stott CE, Delano PH (2014) Use of non-echo-planar diffusion-weighted MR imaging for the detection of cholesteatomas in high-risk tympanic retraction pockets. AJNR Am J Neuroradiol 35:1820–1824
Patel B, Steele K, Pal S, Singh A, Lingam R (2020) Managing postoperative cholesteatoma: second-look surgery or surveillance with diffusion-weighted magnetic resonance imaging. B-ENT 16:197–201
Amoodi H, Mofti A, Fatani NH, Alhatem H, Zabidi A, Ibrahim M (2022) Non-echo planar diffusion-weighted imaging in the detection of recurrent or residual cholesteatoma: a systematic review and meta-analysis of diagnostic studies. Cureus 14:e32127
Lingam RK, Bassett P (2017) A meta-analysis on the diagnostic performance of non-echoplanar diffusion-weighted imaging in detecting middle ear cholesteatoma: 10 years on. Otol Neurotol 38:521–528
Pai I, Crossley E, Lancer H, Dudau C, Connor S (2019) Growth and late detection of post-operative cholesteatoma on long term follow-up with diffusion weighted magnetic resonance imaging (DWI MRI): a retrospective analysis from a single UK centre. Otol Neurotol 40:638–644
Acknowledgements
This paper was endorsed by the Executive Council of the European Society of Radiology (ESR) and the Executive Committee of the European Society of Head and Neck Radiology (ESHNR) in July 2024.
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor for this publication is S.C.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was not required.
Ethical approval
Institutional Review Board approval was not required.
Study subjects or cohorts overlap
Not applicable.
Methodology
-
Practice recommendations
Additional information
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article belongs to the ESR Essentials series guest edited by Marc Dewey (Berlin/Germany).
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Touska, P., Connor, S.E.J. ESR Essentials: imaging of middle ear cholesteatoma—practice recommendations by the European Society of Head and Neck Radiology. Eur Radiol (2024). https://doi.org/10.1007/s00330-024-11021-x
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00330-024-11021-x